Keros Therapeutics, Inc.
KROS
$11.34
$0.312.81%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 287.42M | 693.47M | 690.22M | 720.54M | 559.93M |
| Total Receivables | 20.85M | 5.57M | 17.74M | 19.37M | 4.46M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.76M | 4.16M | 5.56M | 1.62M | 1.76M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.40M | 16.12M | 19.30M | 17.98M | 22.74M |
| Total Current Assets | 315.43M | 719.31M | 732.81M | 759.51M | 588.89M |
|
|
|||||
| Total Current Assets | 315.43M | 719.31M | 732.81M | 759.51M | 588.89M |
| Net Property, Plant & Equipment | 21.14M | 22.03M | 22.91M | 23.14M | 23.49M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.45M | 1.45M | 1.45M | 1.91M | 3.51M |
| Total Assets | 338.02M | 742.78M | 757.17M | 784.56M | 615.89M |
|
|
|||||
| Total Accounts Payable | 1.97M | 2.30M | 5.27M | 6.64M | 4.60M |
| Total Accrued Expenses | 12.45M | 14.96M | 19.62M | 16.76M | 20.45M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.41M | 2.32M | 2.23M | 2.10M | 1.98M |
| Total Finance Division Other Current Liabilities | 3.59M | 4.51M | 7.60M | 13.88M | 416.00K |
| Total Other Current Liabilities | 3.59M | 4.51M | 7.60M | 13.88M | 416.00K |
| Total Current Liabilities | 20.41M | 24.09M | 34.71M | 39.38M | 27.45M |
|
|
|||||
| Total Current Liabilities | 20.41M | 24.09M | 34.71M | 39.38M | 27.45M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 14.48M | 15.11M | 15.72M | 16.31M | 16.88M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 34.89M | 39.20M | 50.43M | 55.69M | 44.33M |
|
|
|||||
| Common Stock & APIC | 1.17B | 1.16B | 1.16B | 1.15B | 1.14B |
| Retained Earnings | -481.77M | -458.30M | -451.02M | -420.33M | -568.78M |
| Treasury Stock & Other | -384.56M | -- | -- | -- | -- |
| Total Common Equity | 303.13M | 703.58M | 706.73M | 728.87M | 571.55M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 303.13M | 703.58M | 706.73M | 728.87M | 571.55M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 303.13M | 703.58M | 706.73M | 728.87M | 571.55M |
|
|
|||||